Trials / Completed
CompletedNCT01192945
Non-interventional Study With Azacitidin (Vidaza®)
Piaza - Non-interventional Study on the Efficacy and Safety of Azacitidin (Vidaza®) in Patients With Myelodysplastic Syndromes (MDS, INT-2 or High Risk), AML (WHO 20-30% Blasts), or CMMoL (10-29% Bone Marrow Blasts Without Myeloproliferative Disorder)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this non-interventional study is to collect data on the efficiency and safety of Azacitidin in the routine application.
Conditions
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2014-12-01
- Completion
- 2015-11-01
- First posted
- 2010-09-01
- Last updated
- 2015-11-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01192945. Inclusion in this directory is not an endorsement.